JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 45 filers reported holding JANUX THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,592,000 | +8.5% | 1,150,000 | +27.8% | 0.03% | +13.0% |
| Q2 2023 | $10,683,000 | -1.9% | 900,000 | 0.0% | 0.02% | -4.2% |
| Q1 2023 | $10,890,000 | +17.9% | 900,000 | +28.4% | 0.02% | +9.1% |
| Q4 2022 | $9,233,039 | +70.5% | 701,066 | +75.3% | 0.02% | +69.2% |
| Q3 2022 | $5,416,000 | +10.9% | 400,000 | 0.0% | 0.01% | +18.2% |
| Q2 2022 | $4,884,000 | -14.9% | 400,000 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $5,736,000 | -27.3% | 400,000 | 0.0% | 0.01% | -21.4% |
| Q4 2021 | $7,892,000 | -8.8% | 400,000 | 0.0% | 0.01% | -17.6% |
| Q3 2021 | $8,652,000 | -22.9% | 400,000 | -11.1% | 0.02% | -22.7% |
| Q2 2021 | $11,228,000 | – | 450,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,670,644 | $216,333,000 | 3.47% |
| 5AM Venture Management, LLC | 446,266 | $11,134,000 | 2.80% |
| Samsara BioCapital, LLC | 607,949 | $15,168,000 | 1.87% |
| EcoR1 Capital, LLC | 1,411,975 | $35,229,000 | 1.32% |
| Logos Global Management LP | 547,122 | $13,651,000 | 1.15% |
| BVF INC/IL | 1,176,681 | $29,358,000 | 1.10% |
| Orbimed Advisors | 3,466,386 | $86,486,000 | 0.88% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 700,000 | $17,465,000 | 0.31% |
| Pinz Capital Management, LP | 32,100 | $801,000 | 0.24% |
| Woodline Partners LP | 334,260 | $8,340,000 | 0.16% |